Novavax | NVAX - Pre Tax Profit

Stock Price
8.55
Daily Change
0.16 1.85%
Monthly
-15.23%
Yearly
37.82%
Q2 Forecast
7.90

Novavax reported $17.9M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Adma Biologics USD 61.59M 14.07M Dec/2025
Agenus USD -10.61M 263.52M Dec/2025
AstraZeneca USD 3.24B 117M Sep/2025
BioCryst Pharmaceuticals USD 248.02M 235.89M Dec/2025
Cassava Sciences USD -10.81M 33.41M Sep/2025
Geron USD -31.14M 12.72M Dec/2025
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
MannKind USD -20.93M 28.71M Dec/2025
Merck USD 6.74B 22M Sep/2025
Minerva Neurosciences USD 22.51M 30.74M Sep/2024
Moderna USD -187M 631M Sep/2025
Novartis USD 5.17B 637M Sep/2025
Novavax USD 17.9M 220.94M Dec/2025
Pfizer USD 3.33B 290M Sep/2025
Sanofi EUR -1.16B 5.5B Dec/2025
Sarepta Therapeutics USD -407.67M 213.63M Dec/2025
TG Therapeutics USD 45.09M 19.18M Dec/2025